Rimazolium
Chemical compound
- N02BG02 (WHO)
- 3-(Ethoxycarbonyl)-1,6-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-1-ium
- 35615-72-6 Y
28610-84-6 (mesylate)
- 71940
- 64949
- 967Y95129A
- Interactive image
- O=C1C(=C/[N+](=C2\N1C(CCC2)C)C)\C(=O)OCC
InChI
- InChI=1S/C13H19N2O3/c1-4-18-13(17)10-8-14(3)11-7-5-6-9(2)15(11)12(10)16/h8-9H,4-7H2,1-3H3/q+1
- Key:JOWRFSPJFXLGGY-UHFFFAOYSA-N
Rimazolium is a non-narcotic analgesic.[1][2] It is usually formulated as the mesylate salt, rimazolium metilsufate.
References
- ^ a b Merck Index, 11th Edition, 8222
- ^ Furst S, Gyires K, Knoll J (April 1988). "Analgesic profile of rimazolium as compared to different classes of pain killers". Arzneimittel-Forschung. 38 (4): 552–7. PMID 3261171.
- v
- t
- e
modulators
Calcium blockers |
|
---|---|
Sodium blockers |
|
Potassium openers |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e